Clinical consultation: The pharmacist’s role in hydroxyurea management for sickle cell disease
Bibliographic record
Abstract
PURPOSE: Sickle cell disease (SCD) is a genetic disorder caused by a mutation in the β-globin gene, leading to the production of abnormal sickle hemoglobin (HbS). This clinical consultation explores the pivotal role of hydroxyurea as a disease-modifying therapy in SCD and examines how pharmacist-led interventions can optimize its use to improve patient outcomes. SUMMARY: Hydroxyurea increases fetal hemoglobin (HbF) production, reducing HbS polymerization and lowering the frequency of vaso-occlusive crises, acute chest syndrome, and other complications. Despite its proven efficacy, barriers such as poor adherence, inadequate patient education, and suboptimal dosing hinder its effective use. Pharmacists, as integral members of the multidisciplinary care team, are ideally positioned to address these challenges. By providing patient education, regular laboratory monitoring, and dose titration to the maximum tolerated dose (MTD), pharmacists can enhance hydroxyurea's therapeutic benefits. Studies have shown that pharmacist-managed protocols significantly improve adherence, increase the proportion of patients achieving MTD, and lead to better clinical outcomes, such as higher HbF levels and fewer hospitalizations. Although emerging treatments such as gene therapies offer promise, hydroxyurea remains the most accessible and effective option for many patients. CONCLUSION: Pharmacists play a crucial role in optimizing hydroxyurea therapy for patients with SCD by improving adherence and maximizing dosing strategies. Their involvement ensures that more patients experience the full therapeutic benefits of hydroxyurea, contributing to better long-term outcomes. Expanding pharmacist engagement in SCD management will continue to be essential, particularly as new treatments are developed.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.003 | 0.001 |
| Bibliometrics | 0.000 | 0.001 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".